Overview

Gender

male

A native of Austria, Gerhard Mayr received a master’s degree in chemical engineering from the Swiss Federal Institute of Technology (Zurich, Switzerland) in 1969, and a master of business administration degree from Stanford University in 1972. In March 2004, he retired as executive vice president of pharmaceutical operations at Eli Lilly & company after 32 years of service. He had been responsible for global pharmaceutical operations and sales and marketing worldwide at Lilly – a leading innovation-driven corporation.

Gerhard Mayr is a member of the Board of UCB since 2005 and serves as Chairman since 2012. He is also a member of the Board of Almirall S.A. (since 2012), member of the board of the Vienna Science, Research and Technology Foundation (since 2002) and a member of the board of Project Hope, USA (since 2002). He is a member of the circle of patrons of INSEAD Business School (since 2000).

His former activities and functions are:

1. Member of the board of Lonza Group Ltd. (2006-2013)
2. Member of the board of Alcon, Inc. (2007-2010)
3.Member of the board of OMV AG, Vienna (2002-2009)
4.Member of the board of Bank Austria AG, Vienna (1998-2006)
5.Member of U.S. – Egypt President’s Council (1999-2004)
6.Member of the board of the European Federation of the Pharmaceutical Industry (1995-1997 and 2000-2002)
7.Chairman of the International Executive Committee of the Pharmaceutical Research
Manufacturers of America
8.Chairman of the Europe Committee of the Pharmaceutical Research Manufacturers of
America
9.Executive Vice President of Eli Lilly & Company with responsibility for global pharmaceutical operations (1999-2004) President of Lilly Intercontinental (1997-1999)
10. President of Lilly International (1993-1997)
11. Joined Eli Lilly in 1972 as Sales Representative